Drug General Information
Drug ID
D0R9CH
Former ID
DNC007526
Drug Name
ZK-810388
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528872]
Formula
C23H20Cl3N5O4S
Canonical SMILES
CN(CC1=CSC(=C1Cl)C(=O)NC2=C(C=C(C=C2C(=O)NC3=NC=C(C=C3)<br />Cl)Cl)OC)C4=NCCO4
InChI
1S/C23H20Cl3N5O4S/c1-31(23-27-5-6-35-23)10-12-11-36-20(18(12)26)22(33)30-19-15(7-14(25)8-16(19)34-2)21(32)29-17-4-3-13(24)9-28-17/h3-4,7-9,11H,5-6,10H2,1-2H3,(H,30,33)(H,28,29,32)
InChIKey
FBXIHZSULWMHJY-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasma kallikrein Target Info Inhibitor [528872]
Coagulation factor Xa Target Info Inhibitor [528872]
KEGG Pathway Complement and coagulation cascadeshsa04610:Complement and coagulation cascades
NetPath Pathway AndrogenReceptor Signaling Pathway
PANTHER Pathway Blood coagulationP00011:Blood coagulation
Pathway Interaction Database Beta2 integrin cell surface interactions
PathWhiz Pathway CoagulationPW000562:Coagulation
Reactome Intrinsic Pathway of Fibrin Clot Formation
Activation of Matrix MetalloproteinasesR-HSA-140834:Extrinsic Pathway of Fibrin Clot Formation
Common Pathway of Fibrin Clot Formation
Gamma-carboxylation of protein precursors
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
Removal of aminoterminal propeptides from gamma-carboxylated proteins
WikiPathways Complement and Coagulation Cascades
Human Complement System
Blood Clotting Cascade
Formation of Fibrin Clot (Clotting Cascade)WP558:Complement and Coagulation Cascades
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
Formation of Fibrin Clot (Clotting Cascade)
References
Ref 528872J Med Chem. 2007 Jun 28;50(13):2967-80. Epub 2007 May 31.Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.
Ref 528872J Med Chem. 2007 Jun 28;50(13):2967-80. Epub 2007 May 31.Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.